Daily intake of short-chain fatty acids and its effects on metabolic health
Official title: The Impact of 12 Weeks Intervention With Plant-based Oat Drink Rich in Short-chain Fatty Acids on Postprandial Lipidemia in Individuals at Risk for Metabolic Syndrome
Run by KU Leuven · NCT06951386 · Data updated 2026-11-12
This study is testing whether drinking a daily beverage with short-chain fatty acids can help people at risk for metabolic syndrome improve their heart and metabolic health over 12 weeks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 50 (estimated) |
| Sponsor | KU Leuven Academic / other |
| Locations | 1 site (Leuven, Vlaams-Brabant) |
| Status | Recruiting |
| Started | February 11, 2025 |
| Main results expected | February 28, 2026 |
| Study ends | February 28, 2026 |
| Registry record updated | May 4, 2025 |
| Trial ID | NCT06951386 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults with central obesity and at least one additional risk factor for metabolic syndrome.
✕Probably not a fit
Patients with gastrointestinal disorders or those on specific diets such as weight loss or vegan may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of a daily drink enriched with short-chain fatty acids (SCFAs) on cardiometabolic health in individuals at risk for metabolic syndrome over a 12-week period. Participants will be randomly assigned to consume either the SCFA-enriched drink or a control oat drink. Key metabolic parameters such as blood pressure, body weight, waist and hip circumference, body composition, energy expenditure, glucose, insulin, and blood lipids will be measured before and after the intervention. The study aims to determine if daily SCFA intake can improve these health markers.
Why it matters
Potential benefit: If successful, this study could lead to dietary recommendations that improve cardiometabolic health and reduce the risk of metabolic syndrome.
How similar studies have gone: Other studies have shown promising results with dietary interventions involving short-chain fatty acids, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * male and female participants * central obesity ( BMI ≥ 25 kg/m² or waist circumference ≥ 80 cm for women/ ≥ 94 cm for men) * One additional risk factor for metabolic syndrome: 1. Insulin resistance (HOMA-IR ≥ 1.7 or fasting glucose ≥ 100 mg/dl) 2. Triglyceride concentration ≥ 150 mg/dl 3. HDL-cholesterol \< 40 mg/dl for women/ \< 50 mg/dl for men 4. Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg * knowledge of English Exclusion Criteria: * gastrointestinal disorders such as IBD, IBS, celiac disease, chronic constipation, chronic diarrhoea * history of abdominal surgery, except for appendectomy * Use of antihypertensive, cholesterol lowering, glucose-regulating drugs and corticosteroids * Use of antibiotics 3 months prior to the start or during the study * Use of probiotics and prebiotics 2 weeks prior to the start of the study/ during the study * Being on weight loss, gluten-free, lactose-free or vegan diet * Pregnancy, lactation or wish to become pregnant * Previous or current substance/ alcohol dependence or abuse * Hyper- or hypothyroidism * Allergy or intolerance to oat milk
Where it's running
-
KU Leuven/ UZ Leuven
Leuven, Vlaams-Brabant, Belgium Recruiting
Study contacts
- Principal investigator: Kristin Verbeke, Prof. — KU Leuven
- Study coordinator: Riet Rosseel, Msc
- Email: riet.rosseel@kuleuven.be
- Phone: +3216373428
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Micronutrient Enhancement for Development and Health in Adolescent Girls
This study tests whether daily micronutrient supplements (MMS or MMS+), compared with weekly iron-folic acid, can improve school performance and growth in 10- to 18-year-old girls in rural Bangladesh.
-
Diet, zinc, inflammation, and body composition in multi-ethnic reproductive-age women in Jakarta
This project will see if usual dietary patterns and hair zinc levels are linked to body composition, inflammation (TNF-α), and blood pressure in women aged 19–49 who live in Jakarta.
-
A cycling program to improve health in adolescents commuting to school
This study is testing whether a school cycling program can help improve the health of teenagers who commute to school.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Exercise Self-Efficacy, Body Composition, and Activity in Men with Low Testosterone
This study tests how confident men on testosterone therapy are at staying active and whether that confidence links body fat and lean mass with how much they exercise.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.